We are live on ! Find out more
OCGN icon

Ocugen

25 hedge funds and large institutions have $19.2M invested in Ocugen in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

9% more funds holding

Funds holding: 2325 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $19.9M → $19.2M (-$720K)

Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
8
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
-$19K -192 Closed

OCGN Hedge Fund Activity: Q1 2017 in Review

25 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q1 2017, worth a combined $19.2M — down 3.6% from $19.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new OCGN positions and 3 closed out — a net gain of 5 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $467K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.11M sold.

  • 25 institutional investors held Ocugen (OCGN) as of Q1 2017, up from 23 in Q4 2016.
  • Funds reported $19.2M of Ocugen stock for Q1 2017, down 3.6% quarter-over-quarter.
  • 8 funds opened new Ocugen positions in Q1 2017 and 3 closed out, a net change of +5 holders.
  • The largest Ocugen buyer in Q1 2017 was Vanguard Group, an estimated $467K added.
  • The largest Ocugen seller in Q1 2017 was Armistice Capital, an estimated $2.11M sold.

Based on aggregated 13F filings for Q1 2017.